HHS can require approval for drugmakers to apply 340B rebate models, court rules
The government “did not act contrary to the law” by requiring drugmakers to seek approval before implementing proposed new 340B rebate models, a federal judge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
